News shared by:

336 Articles
24 Nov 2018
Deals this week: Mundipharma, Ligand Pharmaceuticals

Mundipharma has signed an agreement with Kolon Life Sciences to secure rights for osteoarthritis therapy Invossa in Japan. The agreement is worth up to $600m and will involve the...

24 Nov 2018
The European Investment Bank provides €24 million funding to F2G Biotech

The European Investment Bank (EIB) is lending €24 million to Austrian F2G Biotech GmbH, a research-intensive company, focusing on the discovery and development of novel drugs to treat...

22 Nov 2018
WHO and EU commit to work together to accelerate progress on health

Dr Tedros Adhanom Ghebreyesus, Director-General of WHO has completed a series of meetings with President Juncker and senior European Commission officials. He also signed a joint statement with the...

22 Nov 2018
Cambrex signs $252m agreement to acquire Avista Pharma

Generic active pharmaceutical ingredients (APIs) manufacturer Cambrex has signed a $252m definitive agreement to purchase Avista Pharma Solutions (Avista). A contract developer, manufacturer and...

20 Nov 2018
Roivant and iNtRON sign licensing deal for SAL200

Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to treat infectious diseases caused by...

20 Nov 2018
Most FDA required post-marketing drug studies are missing

The FDA requires drugs to be tested on children after they have been approved for adults, however two thirds of these are not happening… The FDA requires clinical studies of new drugs in...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×